As the smallpox epidemic spreads, Siga Technologies'

Tpoxx oral antiviral smallpox appears to be in high demand

The company said Thursday it secured an estimated $ 13 million

in drug orders, including a $ 11 million

tender from two new countries and a $ 2 million order.

countries in the Asia-Pacific region with a contract for pills.

Phil Gomez, CEO of Siga, said in a statement

 of inquiries about access to Tpoxx.